Lista de obras - Sipeky C - Dominio Público Uruguay

4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation

scientific article published on 01 October 2019

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genetic risk score to personalize prostate cancer screening, applied to population data

scientific article published on 24 June 2020

Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome

artículo científico publicado en 2007

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

artículo científico publicado en 2018

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

artículo científico publicado en 2018

Genetic biomarkers to guide poly (ADP-ribose) polymerase inhibitor precision treatment of prostate cancer

artículo científico publicado en 2020

Genome-wide association study of prostate cancer-specific survival

artículo científico publicado en 2015

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

artículo científico publicado en 2018

Haplogroup analysis of vitamin-K epoxide reductase (VKORC1) gene: novel element in the optimization of anticoagulant therapy

artículo científico publicado en 2008

Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation

artículo científico publicado en 2019

Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view

scientific article published on 02 December 2019

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

artículo científico publicado en 2018

Prevalence of SLC22A4 1672T and SLC22A5 -207C combination defined TC haplotype in Hungarian ulcerative colitis patients.

artículo científico publicado en 2007

ShAn: An easy-to-use tool for interactive and integrated variant annotation

artículo científico publicado en 2020

The effect of sample size on polygenic hazard models for prostate cancer

artículo científico publicado en 2020

Vitamin K epoxide reductase complex 1 (VKORC1) haplotypes in healthy Hungarian and Roma population samples.

artículo científico publicado en 2009

[Mitochondrial DNA and its mutations: new advances in a new field]

artículo científico publicado en 2007

[Possible role of selected IGR and SLC22A4/SLC22A5 loci in development of inflammatory bowel diseases].

artículo científico publicado en 2009

[Significance of thiopurine s-methyltransferase gene test in a clinical case].

artículo científico publicado en 2012

Lista de obras de Sipeky C

4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genetic risk score to personalize prostate cancer screening, applied to population data

Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

Genetic biomarkers to guide poly (ADP-ribose) polymerase inhibitor precision treatment of prostate cancer

Genome-wide association study of prostate cancer-specific survival

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

Haplogroup analysis of vitamin-K epoxide reductase (VKORC1) gene: novel element in the optimization of anticoagulant therapy

Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation

Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

Prevalence of SLC22A4 1672T and SLC22A5 -207C combination defined TC haplotype in Hungarian ulcerative colitis patients.

ShAn: An easy-to-use tool for interactive and integrated variant annotation

The effect of sample size on polygenic hazard models for prostate cancer

Vitamin K epoxide reductase complex 1 (VKORC1) haplotypes in healthy Hungarian and Roma population samples.

[Mitochondrial DNA and its mutations: new advances in a new field]

[Possible role of selected IGR and SLC22A4/SLC22A5 loci in development of inflammatory bowel diseases].

[Significance of thiopurine s-methyltransferase gene test in a clinical case].